Zymeworks (ZYME) Non-Current Assets (2021 - 2026)

Zymeworks (ZYME) reported Non-Current Assets of $92.5 million for Q1 2026, down 22.28% on a YoY basis from $119.1 million in Q1 2025, and down 5.34% sequentially from $97.8 million in Q4 2025.

Zymeworks (ZYME) Non-Current Assets (2021 - 2026) Analysis & Trends

Zymeworks (ZYME) has 6 years of Non-Current Assets data on file, last reported at $92.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Assets fell 22.28% year-over-year to $92.5 million; the trailing twelve-month figure through Mar 2026 stood at $408.1 million (down 26.76% YoY), and the FY2025 full-year result was $97.8 million, down 39.89% from the prior year.
  • Non-Current Assets retreated to $92.5 million in Q1 2026, from $97.8 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $181.7 million in Q3 2023 to a low of $92.5 million in Q1 2026.
  • A 5-year average of $136.3 million and a median of $132.1 million in 2024 frame the typical range for Non-Current Assets.
  • Across the five-year window, Non-Current Assets surged 65.8% in 2023 and tumbled 39.89% in 2025, its largest moves.
  • Tracing ZYME's Non-Current Assets over 5 years: stood at $104.0 million in 2022, then soared by 61.46% to $168.0 million in 2023, then slipped by 3.16% to $162.6 million in 2024, then plunged by 39.89% to $97.8 million in 2025, then decreased by 5.34% to $92.5 million in 2026.
  • Business Quant data shows ZYME's Non-Current Assets at $92.5 million in Q1 2026, $97.8 million in Q4 2025, and $105.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 Zymeworks 1.73 Bn 1.36 Bn - 92.54 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 92.54 Mn
Dec 31, 2025 97.76 Mn
Sep 30, 2025 105.56 Mn
Jun 30, 2025 112.26 Mn
Mar 31, 2025 119.06 Mn
Dec 31, 2024 162.64 Mn
Sep 30, 2024 143.38 Mn
Jun 30, 2024 132.14 Mn
Mar 31, 2024 159.93 Mn
Dec 31, 2023 167.95 Mn
Sep 30, 2023 181.73 Mn
Jun 30, 2023 181.72 Mn
Mar 31, 2023 174.37 Mn
Dec 31, 2022 104.02 Mn
Sep 30, 2022 109.61 Mn
Dec 31, 2021 100.91 Mn